International Clinical Trial: A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470879) titled 'A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis' on March 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Colitis, Ulcerative

Intervention: Drug: Etrasimod

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 31, 2026

Target Sample Size: 24

Countries of Recruitment: Japan

To know more, visit https://clinicaltrials.gov/study/NCT07470879

Disclaimer: Curated by HT...